Brainstorm Cell Therapeutics Inc (STU:GHD)
€ 2.979 0 (0%) Market Cap: 8.70 Mil Enterprise Value: 9.34 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 29/100

Brainstorm Cell Therapeutics Inc Annual Shareholders Meeting Transcript

Jan 10, 2023 / 03:00PM GMT
Release Date Price: €22.12 (+1.55%)
Operator

Hello, and welcome to the Brainstorm Cell Therapeutics, Inc annual meeting of stockholders. Please note that today's meeting is being recorded. During the meeting, we'll have a question and answer session. You can submit questions or comments through the ask-a-question box.

It is now my pleasure to turn today's meeting over to Chaim Lebovits, Chief Executive Officer of Brainstorm Cell Therapeutics, Inc. Mr. Lebovits, the floor is yours.

Chaim Lebovits
Brainstorm Cell Therapeutics Inc. - CEO

Thank you. Good morning. I'm Chaim Lebovits, Chief Executive Officer of Brainstorm Cell Therapeutics, Inc. Welcome to the Brainstorm 2023 annual meeting. With us today are Dr. Stacy Lindborg, Co-CEO; and Alla Patlis, Chief Financial Officer, will be available following the formal part of the meeting to respond to questions from stockholders. Notice of this meeting was sent beginning on December 13, 2020, to stockholders of record as of the record time which was November 29, 2022.

This meeting is being held in accordance with the corporation's bylaws and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot